Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

AbbVie Could Be The Next Gilead
Seeking Alpha
Thu, 10/27/16 - 10:14 pm
Tags:
AbbVie, Gilead Sciences
3 Key Questions for Gilead Sciences, Inc. in Q3
Motley Fool
Wed, 10/26/16 - 09:06 am
Tags:
Gilead Sciences, earnings
Good and bad news for Gilead
BioPharma Dive
Sat, 10/22/16 - 03:13 pm
Tags:
Gilead Sciences, selonsertib, HIV, hepatitis C, NASH
Gilead Fatty Liver Drug Advances to Phase 3
Investopedia
Fri, 10/21/16 - 10:05 am
Tags:
Gilead Sciences, non-alcoholic fatty liver disease, NASH, selonsertib
Gilead asks FDA to expand exclusivity for a key HIV drug
Stat/Pharmalot
Thu, 10/20/16 - 03:33 pm
Tags:
Gilead Sciences, FDA, HIV, Stribild
41 Billion Reasons Why Gilead Sciences Might Need New Management
Motley Fool
Wed, 10/19/16 - 06:43 pm
Tags:
Gilead Sciences, M&A
Allergan May Have Outbid Gilead For Tobira, Setting The Backdrop For A Showdown In NASH
Seeking Alpha
Wed, 10/19/16 - 10:44 am
Tags:
Allergan, Gilead Sciences, Tobira, NASH, Cenicriviroc
Gilead Sciences: What to Expect When You’re Expecting Earnings
Barron's
Mon, 10/17/16 - 11:51 am
Tags:
Gilead Sciences, earnings
What’s New with Gilead Sciences?
Market Realist
Mon, 10/10/16 - 09:16 am
Tags:
Gilead Sciences, GS-5745, Truvada, Odefsey, Epclusa
Gilead May Lose Sovaldi’s European Patent
Investopedia
Fri, 10/7/16 - 10:25 pm
Tags:
Gilead Sciences, Sovaldi, Europe, patents, hepatitis C
FDA Warning Adds to Gilead’s Drug Woes (GILD)
Investopedia
Fri, 10/7/16 - 08:59 am
Tags:
FDA, warnings, hepatitis C, Gilead Sciences
Nope, Gilead Sciences Won’t Get Bought out
Motley Fool
Tue, 10/4/16 - 10:22 am
Tags:
Gilead Sciences, M&A
Two Big Biotechs Flash Bearish Signals
Investopedia
Sun, 10/2/16 - 10:13 am
Tags:
biotech, Celgene, Gilead Sciences
Gilead May Not Acquire Galapagos, For Now (GILD, GLPG)
Investopedia
Thu, 09/29/16 - 08:16 am
Tags:
Gilead Sciences, Galapagos
Will Gilead (GILD) Stock Be Helped by Positive Crohn's Drug Results?
TheStreet.com
Mon, 09/26/16 - 03:25 pm
Tags:
Gilead Sciences, Crohn's Disease, filgotinib, Galapagos
How Gilead Dominates the HCV Space
Market Realist
Mon, 09/26/16 - 09:50 am
Tags:
Gilead Sciences, hepatitis C, Sovaldi, Harvoni
Gilead Sciences: Are Hepatitis C Sales Getting Better?
Barron's
Fri, 09/23/16 - 10:13 pm
Tags:
Gilead Sciences, hepatitis C, Harvoni, Sovaldi
Gilead Sciences: Another Blow to R&D Strategy
Barron's
Fri, 09/23/16 - 10:06 pm
Tags:
Gilead Sciences, R&D, ulcerative colitis, GS-5745
Will Gilead Make a Good Fit for Allergan?
Investopedia
Fri, 09/23/16 - 09:56 am
Tags:
Gilead Sciences, Allergan, M&A
Biotech: Why NASH is So Hot Right Now
Barron's
Wed, 09/21/16 - 10:55 pm
Tags:
NASH, Allergan, M&A, Gilead Sciences, Tobira Therapeutics, Galmed Pharmaceuticals

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.